FDA product code OQX: Self-Contained Blood Grouping
OQX is the FDA product code for self-contained blood grouping. It is a Class II device, regulated under 21 CFR 864.9175 and reviewed by the Hematology panel. Devices under OQX reach the market by 510(k); FDA lists no cleared 510(k)s for it. FDA has posted 1 recall for OQX devices, 1 initiated in the last five years.
Definition
Intended for single use for individual blood group determination for educational and informational purposes
Classification
| Field | Value |
|---|---|
| Device name | Self-Contained Blood Grouping |
| Device class | Class II |
| Regulation | 21 CFR 864.9175 |
| Review panel | HE — Hematology |
| Medical specialty | Hematology |
| Premarket route | 510(k) |
Recalls for OQX devices
1 product recalls in 1 recall events; 1 initiated in the last five years and 1 still open. Most recent: 2025-11-03.
| Year | Recalls |
|---|---|
| 2025 | 1 |
Frequently asked questions
What is FDA product code OQX?
OQX is the FDA product code for self-contained blood grouping. It is a Class II device, regulated under 21 CFR 864.9175 and reviewed by the Hematology panel.
What device class is OQX?
Class II, regulation 21 CFR 864.9175. Typical premarket route: 510(k).
Have OQX devices been recalled?
Yes: 1 product recalls across 1 recall events; the most recent began 2025-11-03.
Next steps
- Run an FDA pathway report with predicate devices for product code OQX
- Run a recall and safety report across every OQX manufacturer
- Watch product code OQX for new clearances and recalls
Compiled by Caduvo from public U.S. FDA records. Applicant names are shown as FDA records them. Review days run from FDA receipt to decision. Not reviewed or endorsed by FDA. Not regulatory advice. Report an error. Data and corrections policy.
All Hematology product codes · FDA product code lookup · 510(k) database search · 510(k) review times